Vaccine News and Research

Latest Vaccine News and Research

ODH hosts symposium on ‘Health Information Exchanges’ for research and public health improvement

Today, the Ohio Department of Health (ODH) and Case Western Reserve University School of Medicine's Weatherhead Institute for Family Medicine and Community Health are hosting the second annual Ohio Health Data Symposium, a meeting for research and public health experts. The collaboration's theme is "Health Information Exchanges: Opportunities for Research and Public Health Improvement."

7 Jun 2013

Low levels of vitamin D associated with high levels of hepatitis B virus replication

Researchers from Germany have found that low levels of vitamin D are associated with high levels of hepatitis B virus replication. Findings published online in Hepatology, a journal of the American Association for the Study of Liver Diseases, suggest seasonal fluctuations in vitamin D and HBV levels point to a link in these variables among patients with chronic HBV.

6 Jun 2013

Social networks are tools to fight against infectious diseases in wild chimpanzees

Many think of social networks in terms of Facebook friends and Twitter followers, but for recent University of Georgia doctoral graduate Julie Rushmore, social networks are tools in the fight against infectious diseases.

6 Jun 2013

Research reveals how HIV triggers signal to kill infected immune cell

Untreated HIV infection destroys a person's immune system by killing infection-fighting cells, but precisely when and how HIV wreaks this destruction has been a mystery until now. New research by scientists at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, reveals how HIV triggers a signal telling an infected immune cell to die.

6 Jun 2013

Solid formulations of the recombinant anthrax vaccine: an interview with Dr Mark Carnegie-Brown, CEO, Glide Pharma

Anthrax vaccines have a prominent place in the history of medicine. This goes back to, Pasteur, who while everybody associates with the milk treatment process, also worked on rabies and Anthrax vaccines in cattle.

6 Jun 2013

Cry proteins in Bacillus thuringiensis is lethal to Anopheles gambiae, the principal mosquito vector of malaria

Researchers at The University of Texas at Dallas (UTD), led by Dr. Lee Bulla, have characterized a protein produced by the soil bacterium Bacillus thuringiensis subsp. israelensis (Bti), which is highly toxic against Anopheles gambiae, the principal mosquito vector of malaria.

6 Jun 2013

Medicago reports positive interim results from preclinical trial for H7 VLP vaccine candidate

Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today reported positive interim results from a preclinical trial for an H7N9 Avian Influenza VLP vaccine candidate ("H7 vaccine").

6 Jun 2013

Viewpoints: Kasich on what would Reagan do about Medicaid; The need for more doctors

Leaders in the states that have decided against expanding (Medicaid) have often invoked Reagan conservatism as the reason to oppose extending Medicaid health care coverage to more people. After all, doesn't (Ronald) Reagan embody modern conservatism? He cut taxes, cut government red tape and fought the growth of entitlements. Yes, he did all those things. However, he also expanded Medicaid, not just once but several times (Ohio Gov. John Kasich, 6/2).

6 Jun 2013

New survey data reveal need for specialist nurse support in management of patients with heart failure

One year after the publication of the European Society of Cardiology (ESC) Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012, awareness amongst UK healthcare professionals varies dramatically.

6 Jun 2013

Sustained engagement, partnership needed to implement new treatments for neglected diseases

Days after two landmark resolutions were adopted at the World Health Assembly - on neglected tropical diseases and on research and development, financing and coordination for the health needs of developing countries - over 400 scientists, representatives and ministers of health, ambassadors, national control programme representatives, African regulators, health workers, public health experts, and activists from 21 African countries and 10 others from around the world gather in Nairobi to take stock of health innovation for neglected diseases in Africa over the past decade.

6 Jun 2013

Study: Offering flu vaccines at elementary schools could expand vaccination rates, reduce costs

Offering flu vaccines at elementary schools could expand vaccination rates and reduce costs, according to a new study reported in the scientific journal Vaccine by researchers from UC Davis Health System; the Monroe County, New York, Department of Public Health; University of Rochester Medical Center; and U.S. Centers for Disease Control and Prevention.

6 Jun 2013

Duke University is awarded $2M to initiate new clinical research network on antibacterial resistance

Duke University, Durham, N.C., has been awarded $2 million to initiate a new clinical research network focused on antibacterial resistance. Total funding for the leadership group cooperative agreement award could reach up to $62 million through 2019.

4 Jun 2013

Duke Medicine, UCSF investigators to oversee research program on antibacterial resistance

Investigators at Duke Medicine and the University of California, San Francisco have been selected to oversee a nationwide research program on antibacterial resistance, which includes a focus on the growing unmet challenges associated with methicillin-resistant Staphylococcus aureus and E. coli.

4 Jun 2013

Soligenix receives FDA Fast Track designation for SGX942 to treat patients with oral mucositis

Soligenix, Inc., a clinical stage biopharmaceutical company, announced today that its SGX942 development program for the treatment of oral mucositis as a result of radiation and/or chemotherapy treatment in head and neck cancer patients has received "Fast Track" designation from the US Food and Drug Administration.

3 Jun 2013

NewLink Genetics announces results from two clinical studies with indoximod

NewLink Genetics Corporation, an oncology-focused biopharmaceutical company specializing in immunotherapy, today announced results from two clinical studies with indoximod, an orally administered small molecule drug candidate that inhibits the IDO pathway.

3 Jun 2013

Mount Sinai researchers present landmark studies at ASCO meeting

Icahn School of Medicine at Mount Sinai researchers will present several landmark studies at the 2013 American Society of Clinical Oncology meeting May 31-June 4, 2013 in Chicago, including data on the likelihood of spousal human papillomavirus oral infection, new gene signatures in melanoma, and issues with high readmission rates after cancer surgery.

3 Jun 2013

Twitter: A popular source for receiving and sharing new information about vaccines

Twitter is a popular source for receiving and sharing new information about vaccines, and also a basically reliable one, according to a study published in the June issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).

1 Jun 2013

Report highlights successes in improving maternal health, reducing child mortality

Rapid expansion of programs to prevent HIV transmission to babies and vaccinate children show how results can be achieved in relatively little time.

1 Jun 2013

Research gives hope: Patients' immune system could fight glioblastoma multiforme

Research at Lund University in Sweden gives hope that one of the most serious types of brain tumour, glioblastoma multiforme, could be fought by the patients' own immune system.

31 May 2013

PharmAthene announces lifting of clinical hold on proposed SparVax Phase II study

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the U.S. Food and Drug Administration has lifted the clinical hold previously placed on a proposed Phase II study of SparVax, a next generation recombinant anthrax vaccine.

31 May 2013

Vaccine News and Research

Latest Vaccine News and Research

ODH hosts symposium on ‘Health Information Exchanges’ for research and public health improvement

Low levels of vitamin D associated with high levels of hepatitis B virus replication

Social networks are tools to fight against infectious diseases in wild chimpanzees

Research reveals how HIV triggers signal to kill infected immune cell

Solid formulations of the recombinant anthrax vaccine: an interview with Dr Mark Carnegie-Brown, CEO, Glide Pharma

Cry proteins in Bacillus thuringiensis is lethal to Anopheles gambiae, the principal mosquito vector of malaria

Medicago reports positive interim results from preclinical trial for H7 VLP vaccine candidate

Viewpoints: Kasich on what would Reagan do about Medicaid; The need for more doctors

New survey data reveal need for specialist nurse support in management of patients with heart failure

Sustained engagement, partnership needed to implement new treatments for neglected diseases

Study: Offering flu vaccines at elementary schools could expand vaccination rates, reduce costs

Duke University is awarded $2M to initiate new clinical research network on antibacterial resistance

Duke Medicine, UCSF investigators to oversee research program on antibacterial resistance

Soligenix receives FDA Fast Track designation for SGX942 to treat patients with oral mucositis

NewLink Genetics announces results from two clinical studies with indoximod

Mount Sinai researchers present landmark studies at ASCO meeting

Twitter: A popular source for receiving and sharing new information about vaccines

Report highlights successes in improving maternal health, reducing child mortality

Research gives hope: Patients' immune system could fight glioblastoma multiforme

PharmAthene announces lifting of clinical hold on proposed SparVax Phase II study

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in